Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects
Clinical trial NCT00964665 · TERMINATED
Trial details
- NCT number
- NCT00964665
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-11-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.